Need help locating data?
Data that informs the data visualisations can be found in the Data section of Cancer data in Australia (CdiA). The following table outlines the range of data provided within CdiA and can be used to assist in navigating through the various Excel workbooks of this report.
The table contains links to the various data and the respective visualisations the data informs. The Excel workbooks provide data for the many different cancers presented within each visualisation. Please note that estimates based on projections were made for the following: incidence and prevalence data from 2022 to 2025, National Mortality Database mortality data from 2024 to 2025 and Australian Cancer Database mortality data from 2022 to 2025.
| Book no. | Broad category (and period) | Contents | Relevant visualisations |
|---|---|---|---|
| 1a | Cancer incidence 1982 to 2025 | Cancer incidence age-standardised rates (ASR) Crude cancer incidence rates Segi and WHO cancer incidence ASR Age specific cancer incidence rates by 5-year age groups Cases diagnosed by 5-year age groups | Summary Incidence by age |
| 1b | Cancer incidence 1982 to 2025 | Age-specific cancer incidence rates and counts of cancers diagnosed by 10-year age groups | Incidence by age |
| 1c | Cancer incidence 1982 to 2025 | Age-specific cancer incidence rates and counts of cancers diagnosed by 15-, 20-, 25- and 30-year age groups | Incidence by age |
| 1d | Cancer incidence 1982 to 2025 | Age-specific cancer incidence rates and counts of cancers diagnosed by 35-, 40-, 45- and 50-year age groups | Incidence by age |
| 1e | Cancer incidence projections (2026 to 2035) | Cancer incidence projections (cases, age-standardised rates and crude rates) | n.a. Excel only |
| 2a | Cancer mortality 1971 to 2025 | Cancer mortality data based on the National Mortality Database: Cancer mortality ASRCrude cancer mortality rates Segi and WHO cancer mortality ASR Age-specific cancer mortality rates by 5-year age groups Deaths from cancer by 5-year age groups | Mortality by age |
| 2b | Cancer mortality 1971 to 2025 | Cancer mortality data based on the National Mortality Database: Age-specific cancer mortality rates and deaths from cancer (by 10-year age groups) | Mortality by age |
| 2c | Cancer mortality 1971 to 2025 | Cancer mortality data based on the National Mortality Database: Age-specific cancer mortality rates and deaths from cancer (by 15-, 20-, 25- and 30-year age groups) | Mortality by age |
| 2d | Cancer mortality 1971 to 2025 | Cancer mortality data based on the National Mortality Database: Age-specific cancer mortality rates and deaths from cancer by 35-, 40-, 45- and 50-year age groups | Mortality by age |
| 2e | Cancer mortality 2007 to 2025 | Cancer mortality data based on the Australian Cancer Database: Cancer mortality ASRCrude cancer mortality rates Age-specific cancer mortality rates and deaths by 5-, 10-, 15-, 20-, 25-, 30-, 35-, 40-, 45- and 50-year age groups. | Mortality by age |
| 3a | Cancer survival 1987–1991 to 2017–2021 periods | Cancer survival rates Cancer survival rates by 5-year age groups (2016–2020 only) Conditional cancer survival rates | Summary survival |
| 3b | Cancer survival 1987–1991 to 2017–2021 periods | Cancer survival rates Cancer survival rates by 20-year age groups Age-adjusted cancer survival rates | Survival by age |
| 4a | Cancer risk Incidence: 1982 to 2025 Mortality: 1971 for 2025 | Cancer risk adjusted for competing mortality, including: | Risk |
| 4b | Cancer risk Incidence: 1982 to 2025 Mortality: 1971 for 2025 | Cancer risk unadjusted for competing mortality, including: | Risk |
| 4c | Cancer risk Mortality: 2007 to 2025 | Cancer risk adjusted and unadjusted for competing mortality, including: Note: estimates for risk of death in this book are based on cancer deaths from the Australian Cancer Database. | Risk |
| 5 | Age at diagnosis/death Incidence: 1982 to 2021 Mortality: 1971 to 2023 | Median and mean age at cancer diagnosis | |
| 6 | Cancer prevalence as at 31 December 2000 to as at 31 December 2025 | Number of people alive and diagnosed with cancer: within the last year within the last 5 years within the last 40 years Time series prevalence data by age is available for 1-, 5- and 10-year prevalence | Summary -1, 5- and 10-year prevalence as at December 2021. Prevalence - time series by age group from 2000 to 2025 for 1-, 5- and 10-year prevalence and 40-year prevalence for 2021. |
| 7 | State and territory incidence and mortality data 1982 to 2021 | State and territory cancer incidence and mortality ASR State and territory number of cancer cases diagnosed and deaths | State and territory |
| 8 | Cancer incidence and survival by stage 2011 | Proportion of cases diagnosed by stage at diagnosis Cancer survival by stage at diagnosis Stage data is only available for melanoma of the skin, breast cancer in females, lung cancer, prostate cancer and colorectal cancer. | Stage |
| 9a | Cancer incidence by subsite 2000 to 2025 | Cancer incidence counts and rates by ICD-10 4-character subsite (crude and age-standardised rates and age-specific rates by 10-year age groups). Proportion of cancer by subsite (by 10-year age groups). | Cancer incidence by subsite |
| 9b | Cancer incidence by subsite 2000 to 2025 | Cancer incidence counts and rates by ICD-10 4-character subsite (crude and age-standardised rates and age-specific rates by 20-year age groups). Proportion of cancer by subsite (by 20-year age groups). | Cancer incidence by subsite |
| 9c | Cancer survival by subsite, 2002–2006 to 2017–2021 periods | Observed and relative survival rates by ICD-10 4-character (by 10-year age groups) 10-year age group proportions of cases diagnosed by ICD-10 4-character subsite | Cancer survival by subsite |
| 9d | Cancer survival by subsite, 2002–2006 to 2017–2021 periods | Observed and relative survival rates by ICD-10 4-character (by 20-year age groups) 20-year age group proportions of cases diagnosed by ICD-10 4-character subsite | Cancer survival by subsite |
| 10a to 10h and 10l to 10o | Incidence of selected cancers by histology 2001 to 2020 | Incidence counts and rates for selected cancers by histology (crude and age-standardised rates and age-specific rates by 10-year and 20-year age groups). Histology proportions for the selected cancers, by 10-year and 20-year age groups). Book 10a: Appendiceal cancer, breast cancer, brain cancer Book 10b: Colon cancer and colorectal cancer groups Book 10c: Cervical cancer, kidney cancer, liver cancer Book 10d: Lung cancer, melanoma of the skin, mesothelioma Book 10e: Pancreatic cancer, prostate cancer, bladder cancer, thyroid cancer Book 10f: Rectosigmoid junction cancer and rectal cancer groupsBook 10g: vulvar cancer, vaginal cancer and uterine cancer Book 10h: ovarian cancer, fallopian tube cancer, cancer of other female genital organs (excluding fallopian tube), placenta cancer Book 10l: oesophageal cancer, stomach cancer, small intestine cancer, anal cancer Book10n: breast cancer by tumour size Book 10o melanoma of the skin by Breslow thickness | Cancer incidence by histology |
| 10i and 10k | Survival for selected cancers by histology 2007–2011 to 2017–2021 | Observed and relative survival rates for the above selected cancers by histology Book 10i: by 10-year age groups Book 10k: by 20-year age groups | Cancer survival by histology |
| 10j | Cancer by histology frameworks | List of cancer types by histology for each cancer site | n.a. Excel only |
| 10l | Cancer incidence by histology cases diagnosed proportions by age group 2001 to 2021 | Number of cases by 10- and 20-year age groups Proportion of cases 10- and 20-year age groups | Cancer survival by histology |
| 11a | Blood cancer incidence by histology (main reporting) 2003 to 2021 | Finer level blood cancer incidence and rates for various blood cancers using the main blood cancer reporting framework (crude and age-standardised rates and age-specific rates by 10 and 20-year age groups) | Blood cancer incidence by histology (main reporting) |
| 11b | Blood cancer incidence by histology (main reporting) 2003 to 2021 | Incidence proportions of blood cancers by type using the main blood cancer reporting framework (by 10 and 20-year age groups). | Blood cancer incidence by histology (main reporting) |
| 11c | Blood cancer incidence by histology (ICD-10 reporting) 2003 to 2021 | Finer level blood cancer incidence and rates for various blood cancers using the ICD-10 blood cancer reporting framework (crude and age-standardised rates and age-specific rates by 10 and 20-year age groups) | Blood cancer incidence by histology (ICD-10) |
| 11d | Blood cancer incidence by histology (ICD-10 reporting) 2003 to 2021 | Incidence proportions of blood cancers by type using the ICD-10 blood cancer reporting framework (by 10- and 20-year age groups). | Blood cancer incidence by histology (ICD-10) |
| 11e | Blood cancer survival by histology (main reporting) 2007–2011 to 2017–2021 | Observed and relative survival rates for blood cancers using the main blood cancer reporting framework (by 10- and 20-year age groups) | Blood cancer survival by histology (main reporting) |
| 11f to 11g | Blood cancer survival by histology (ICD-10 by histology) 2007–2011 to 2017–2021 | Observed and relative survival rates for blood cancers using the ICD-10 blood cancer reporting framework Book 10f: by 10-year age groups Book 10g: by 20-year age groups | Blood cancer survival by histology (ICD-10 reporting) |
| 11h | Main blood cancer reporting framework | Histology codes for the reported blood cancer groups | n.a. - Excel only |
| 11j | Blood cancer prevalence by histology from 2012 to 2021 | Prevalence counts and rates, by 10- and 20-year age groups Main and ICD-10 reporting frameworks | Blood cancer prevalence by histology (main and ICD-10 reporting) |
| 12a | Neuroendocrine neoplasms incidence by cancer site from | Neuroendocrine neoplasms cases diagnosed and rates, by 10- and 20- year age groups | Neuroendocrine neoplasm incidence and prevalence by cancer site |
| 12b | Neuroendocrine neoplasms prevalence by cancer site as at 31 December 2021 | Neuroendocrine neoplasm prevalence as at 31 December 2021 by 10- and 20-year age groups | Neuroendocrine neoplasm incidence and prevalence by cancer site |
| 12c | Neuroendocrine neoplasms survival by cancer site from 2007–2011 | Neuroendocrine neoplasm 1- to 5-year survival Observed and related survival by 10- and 20-year age groups | Neuroendocrine neoplasm survival by cancer site |
| 12d | Neuroendocrine neoplasms incidence by age proportions by cancer site | Incidence proportions of neuroendocrine neoplasms by cancer site (by 10 and 20-year age groups) | Neuroendocrine neoplasm survival by cancer site |
| 12e | Neuroendocrine neoplasm histology code | Types of neuroendocrine neoplasms and histology coding | n.a. Excel only |
| 13 | Cancer incidence by country and region of birth from 2007–2011 to 2017–2021 | Leading 20 cancers for selected countries and regions of birth. Age-standardised incidence rates and cases diagnosed | Cancer incidence by country and region of birth |
| Pivot | Cancer incidence by 3-character ICD-10 code (1982 to 2021) | Counts of cases diagnosed Age-specific and crude incidence rates | n.a. Excel only |